Media mogul Oprah Winfrey is stepping down from the board of weight loss company Weight Watchers. Mr. Winfrey has been a member of the Board of Directors since 2015. Will not stand for re-election at the company’s general meeting of shareholders in MayWeight Watchers announced on Wednesday.
The news will come at the following times A new class of weight loss mines known GLP-1 — Popular brands like Ozempic, Wegovy, and Zepbound have been putting pressure on Weight Watchers. The company’s stock price fell by 25%. during premarket trading Thursday.
Winfrey said in a statement that Weight Watchers and its chief executive officer “recognize obesity as a chronic disease, work to reduce stigma, and advance conversations about health equity.” He said he will continue to advise (CEO) Sima Sistani.
read more: Weight loss drugs like Ozempic have food industry CEOs ‘scared’ to call Novo Nordisk for advice
Winfrey said she would donate all her Weight Watchers stock to the National Museum of African American History and Culture. Weight Watchers said it supported Winfrey’s decision, adding that it “eliminates any perceived conflict of interest regarding taking weight loss drugs.”
Weight Watchers is losing the battle over GLP-1
A few days later Winfrey admitted in December that she was taking GLP-1weight watchers Launched a program to provide members with prescriptions for popular medications..
This move has so far failed to bear fruit.
Weight Watchers’ net income loss increased 140% to $88.1 million In the three months ended December 30, that was up from $35.8 million in the same period last year.
in contrast, Market leader Novo Nordisk on the rise It doesn’t look like it’s going to end anytime soon.company reported in January it’s 2023 Sales increased by 31% to DKK 232.3 billion ($33.8 billion) from DKK 177 billion ($25 billion) in 2022. It also predicts that sales will increase by up to 26% in 2024.
